These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18958546)
21. The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease. Naganuma M; Fujii T; Watanabe M J Gastroenterol; 2011 Feb; 46(2):129-37. PubMed ID: 21132334 [TBL] [Abstract][Full Text] [Related]
22. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Sandborn WJ; Present DH; Isaacs KL; Wolf DC; Greenberg E; Hanauer SB; Feagan BG; Mayer L; Johnson T; Galanko J; Martin C; Sandler RS Gastroenterology; 2003 Aug; 125(2):380-8. PubMed ID: 12891539 [TBL] [Abstract][Full Text] [Related]
23. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease. Rice SA; Woo PN; El-Omar E; Keenan RA; Ormerod AD BMC Res Notes; 2013 Jan; 6():19. PubMed ID: 23331739 [TBL] [Abstract][Full Text] [Related]
24. Oral tacrolimus treatment of severe colitis in children. Bousvaros A; Kirschner BS; Werlin SL; Parker-Hartigan L; Daum F; Freeman KB; Balint JP; Day AS; Griffiths AM; Zurakowski D; Ferry GD; Leichtner AM J Pediatr; 2000 Dec; 137(6):794-9. PubMed ID: 11113835 [TBL] [Abstract][Full Text] [Related]
25. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Gordon M; Taylor K; Akobeng AK; Thomas AG Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347 [TBL] [Abstract][Full Text] [Related]
26. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204 [TBL] [Abstract][Full Text] [Related]
27. Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients. Ishida K; Inoue T; Fujiwara K; Sakanaka T; Narabayashi K; Nouda S; Okada T; Kakimoto K; Kuramoto T; Kawakami K; Abe Y; Takeuchi T; Murano M; Tokioka S; Umegaki E; Higuchi K World J Gastroenterol; 2013 May; 19(17):2676-82. PubMed ID: 23674875 [TBL] [Abstract][Full Text] [Related]
28. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial. Hart AL; Plamondon S; Kamm MA Inflamm Bowel Dis; 2007 Mar; 13(3):245-53. PubMed ID: 17206671 [TBL] [Abstract][Full Text] [Related]
29. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Casson DH; Eltumi M; Tomlin S; Walker-Smith JA; Murch SH Gut; 2000 Sep; 47(3):436-40. PubMed ID: 10940284 [TBL] [Abstract][Full Text] [Related]
30. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine. Egan LJ; Sandborn WJ; Tremaine WJ Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: a single-center experience. Benson A; Barrett T; Sparberg M; Buchman AL Inflamm Bowel Dis; 2008 Jan; 14(1):7-12. PubMed ID: 17879277 [TBL] [Abstract][Full Text] [Related]
32. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543 [TBL] [Abstract][Full Text] [Related]
33. Methotrexate for induction of remission in refractory Crohn's disease. Alfadhli AA; McDonald JW; Feagan BG Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908 [TBL] [Abstract][Full Text] [Related]
34. Methotrexate for maintenance of remission in Crohn's disease. Patel V; Wang Y; MacDonald JK; McDonald JW; Chande N Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006884. PubMed ID: 25157445 [TBL] [Abstract][Full Text] [Related]
35. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease. Hinterleitner TA; Petritsch W; Aichbichler B; Fickert P; Ranner G; Krejs GJ Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775 [TBL] [Abstract][Full Text] [Related]
36. Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment. Boschetti G; Nancey S; Moussata D; Stefanescu C; Roblin X; Chauvenet M; Stroeymeyt K; Bouhnik Y; Flourié B Dig Liver Dis; 2014 Oct; 46(10):875-80. PubMed ID: 25023007 [TBL] [Abstract][Full Text] [Related]
37. Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Colombel JF; Reinisch W; Mantzaris GJ; Kornbluth A; Rutgeerts P; Tang KL; Oortwijn A; Bevelander GS; Cornillie FJ; Sandborn WJ Aliment Pharmacol Ther; 2015 Apr; 41(8):734-46. PubMed ID: 25728587 [TBL] [Abstract][Full Text] [Related]
38. Tacrolimus Exerts Only a Transient Effectiveness in Refractory Pediatric Crohn Disease: A Case Series. Truffinet O; Martinez-Vinson C; Guerriero E; Hugot JP; Viala J J Pediatr Gastroenterol Nutr; 2017 May; 64(5):721-725. PubMed ID: 27429426 [TBL] [Abstract][Full Text] [Related]
39. Methotrexate for induction of remission in refractory Crohn's disease. Alfadhli AA; McDonald JW; Feagan BG Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475 [TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. Singh S; Murad MH; Fumery M; Sedano R; Jairath V; Panaccione R; Sandborn WJ; Ma C Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1002-1014. PubMed ID: 34688373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]